Gerresheimer AG (XTER:GXI) Buyback Yield % : 0.00 (As of May. 15, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Gerresheimer AG Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Gerresheimer AG's current buyback yield was 0.00%.

Gerresheimer AG Buyback Yield % Historical Data

The historical data trend for Gerresheimer AG's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG Buyback Yield % Chart

Gerresheimer AG Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Buyback Yield %

Get a 7-Day Free Trial

-9.05

Gerresheimer AG Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Buyback Yield %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Gerresheimer AG's Buyback Yield %

For the Medical Instruments & Supplies subindustry, Gerresheimer AG's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gerresheimer AG's Buyback Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Gerresheimer AG's Buyback Yield % falls into.

Gerresheimer AG Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Gerresheimer AG's Buyback Yield for the fiscal year that ended in Nov. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	271.61)	/	2999.799
	=	-9.05%

Gerresheimer AG's annualized Buyback Yield for the quarter that ended in Feb. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(Annualized)			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	*	Annualized Factor	/	Market Cap
	=	- (0	+	0)	*	4	/	3744.136
	=	0.00%

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Feb. 2024) data.

Gerresheimer AG Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Gerresheimer AG (XTER:GXI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (XTER:GXI) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

GXId:UK 0NTI:UK GXI:Germany GXI:Germany GXI:Germany GXI:Austria

Address

Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468

Website

https://www.gerresheimer.com

Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.

Executives

Dietmar Siemssen	Board of Directors
Dr. Lukas Burkhardt	Board of Directors
Andrea Abt	Supervisory Board

Gerresheimer AG (XTER:GXI) Headlines

No Headlines